Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1987-03-09
1988-01-05
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Lymphokine
424 85, 424 89, 424101, 530387, 530388, 530389, 530390, 530391, 530830, A61K 3925
Patent
active
047175648
ABSTRACT:
Normal plasma from donors who have not been vaccinated with a varicella-zoster vaccine can be screened for higher than normal titers of naturally occurring antibody to varicella-zoster virus. Those plasmas with high titers of such antibody can be pooled and fractionated to give hyperimmune globulin. The product may be treated to render it suitable for intravenous injection. Patients with varicella-zoster infection or at risk to such infection, may receive the present product to raise serum titers of varicella-zoster antibody.
REFERENCES:
patent: 3903262 (1975-09-01), Pappenhagen
patent: 4174388 (1979-11-01), McAleer
patent: 4186192 (1980-01-01), Lundblad
patent: 4296024 (1981-10-01), McAleer
patent: 4396608 (1983-08-01), Tenold
patent: 4499073 (1985-02-01), Tenold
patent: 4617379 (1986-10-01), Dobkin
patent: 4665159 (1987-05-01), Dobkin
Zaia, J. Int. Dis. 137, No. 5, 601-604, (1978).
Amer., J. Med., 124-127, Mar. 1984, Paryani.
J. Pediatrics, 105(2), 200-205, (1984), Paryani, published Aug. 1984.
J. Amer-Med., ASSN-251, (11), 1401, 1405, 1409, 1413, (1984), Immunization Practices Advisory Commission.
Giblin James A.
Miles Laboratories Inc.
Schain Howard E.
LandOfFree
High titer varicella-zoster immune globulin for intravenous admi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with High titer varicella-zoster immune globulin for intravenous admi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High titer varicella-zoster immune globulin for intravenous admi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-8219